Murayama Y, Okamoto T, Ogata E, Asano T, Iiri T, Katada T, Ui M, Grubb J H, Sly W S, Nishimoto I
Fourth Department of Internal Medicine, University of Tokyo School of Medicine, Japan.
J Biol Chem. 1990 Oct 15;265(29):17456-62.
The rat insulin-like growth factor II (IGF-II) receptor develops transmembrane signaling functions by directly coupling to a guanine nucleotide-binding protein (G protein) having a 40-kDa alpha subunit, Gi-2, whereas recent studies have indicated that the IGF-II receptor is a molecule identical to the cation-independent mannose 6-phosphate receptor (CI-MPR), a receptor implicated in lysosomal enzyme sorting. In this study, by using vesicles reconstituted with the clonal human CI-MPR and G proteins, we indicated that the CI-MPR could stimulate guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) binding and GTPase activities of Gi proteins in response to IGF-II. The stimulatory effect of IGF-II on Gi-2 depended on the reconstituted amount of the CI-MPR; it could not be found in vesicles reconstituted with Gi-2 alone; and it was also observed on Gi-1 reconstituted with the CI-MPR in phospholipid vesicles. Of interest, such stimulatory effect was not reproduced by Man-6-P in CI-MPR vesicles reconstituted with either G protein. Furthermore, the affinity for Man-6-P-mediated beta-glucuronidase binding to several kinds of native cell membranes was not reduced by 100 microM GTP gamma S. Instead, however, Man-6-P dose-dependently inhibited IGF-II-induced Gi-2 activation with an IC50 of 6 microM in vesicles reconstituted with the CI-MPR and Gi-2. The action of 100 nM IGF-II was completely abolished by 1 mM Man-6-P. Such an inhibitory effect of Man-6-P was reproduced by 4000 times lower concentrations of beta-glucuronidase or similar concentrations of fructose 1-phosphate, but not by mannose or glucose 6-phosphate. These results indicate that the human CI-MPR has two distinct signaling functions that positively or negatively regulate the activity of Gi-2 in response to the binding of IGF-II or Man-6-P.
大鼠胰岛素样生长因子II(IGF-II)受体通过直接与具有40 kDaα亚基的鸟嘌呤核苷酸结合蛋白(G蛋白)Gi-2偶联而发挥跨膜信号传导功能,而最近的研究表明,IGF-II受体是一种与不依赖阳离子的甘露糖6-磷酸受体(CI-MPR)相同的分子,CI-MPR是一种参与溶酶体酶分选的受体。在本研究中,通过使用用克隆人CI-MPR和G蛋白重构的囊泡,我们表明CI-MPR可响应IGF-II刺激Gi蛋白的鸟苷5'-O-(3-硫代三磷酸)(GTPγS)结合和GTP酶活性。IGF-II对Gi-2的刺激作用取决于CI-MPR的重构量;在用单独的Gi-2重构的囊泡中未发现这种作用;在用CI-MPR重构于磷脂囊泡中的Gi-1上也观察到了这种作用。有趣的是,在用任何一种G蛋白重构的CI-MPR囊泡中,甘露糖6-磷酸(Man-6-P)都不能重现这种刺激作用。此外,100 μM GTPγS不会降低Man-6-P介导的β-葡萄糖醛酸酶与几种天然细胞膜的结合亲和力。然而,相反,在由CI-MPR和Gi-2重构的囊泡中,Man-6-P以剂量依赖的方式抑制IGF-II诱导的Gi-2激活,IC50为6 μM。1 mM Man-6-P可完全消除100 nM IGF-II的作用。4000倍低浓度的β-葡萄糖醛酸酶或类似浓度的果糖1-磷酸可重现Man-6-P的这种抑制作用,但甘露糖或葡萄糖6-磷酸则不能。这些结果表明,人CI-MPR具有两种不同的信号传导功能,可根据IGF-II或Man-6-P的结合正向或负向调节Gi-2的活性。